Entain Future Growth
How is Entain forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?
Future Growth Score
4/6Future Growth Score 4/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
46.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 5,130 | 888 | 828 | 985 | 3 |
12/31/2024 | 4,901 | 564 | 682 | 917 | 17 |
12/31/2023 | 4,628 | 363 | 559 | 788 | 19 |
6/30/2022 | 4,158 | 214 | 554 | 763 | N/A |
3/31/2022 | 3,994 | 239 | 505 | 697 | N/A |
12/31/2021 | 3,830 | 264 | 456 | 632 | N/A |
9/30/2021 | 3,792 | 211 | 509 | 678 | N/A |
6/30/2021 | 3,754 | 158 | 563 | 725 | N/A |
3/31/2021 | 3,658 | 125 | 555 | 718 | N/A |
12/31/2020 | 3,562 | 92 | 546 | 710 | N/A |
6/30/2020 | 3,371 | -126 | 320 | 488 | N/A |
3/31/2020 | 3,475 | -135 | 289 | 463 | N/A |
12/31/2019 | 3,578 | -144 | 258 | 437 | N/A |
9/30/2019 | 3,606 | -166 | 249 | 444 | N/A |
6/30/2019 | 3,611 | -178 | 240 | 451 | N/A |
3/31/2019 | 3,273 | -120 | 171 | 374 | N/A |
12/31/2018 | 2,935 | -62 | 102 | 297 | N/A |
9/30/2018 | 2,228 | 26 | 89 | 228 | N/A |
6/30/2018 | 1,521 | 115 | 76 | 160 | N/A |
3/31/2018 | 1,155 | 47 | 96 | 155 | N/A |
12/31/2017 | 790 | -21 | 115 | 149 | N/A |
6/30/2017 | 674 | -101 | 45 | 79 | N/A |
3/31/2017 | 642 | -123 | 13 | 45 | N/A |
12/31/2016 | 618 | -148 | -18 | 12 | N/A |
9/30/2016 | 577 | -93 | -28 | -4 | N/A |
6/30/2016 | 425 | -64 | -36 | -19 | N/A |
3/31/2016 | 298 | -20 | N/A | 6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ENT's forecast earnings growth (46.9% per year) is above the savings rate (1%).
Earnings vs Market: ENT's earnings (46.9% per year) are forecast to grow faster than the UK market (10.2% per year).
High Growth Earnings: ENT's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ENT's revenue (5.9% per year) is forecast to grow faster than the UK market (4.2% per year).
High Growth Revenue: ENT's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ENT's Return on Equity is forecast to be low in 3 years time (18%).